Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prevalence of Metabolic Syndrome in Atahualpa

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Oscar H. Del Brutto, MD, Hospital Clínica Kennedy
ClinicalTrials.gov Identifier:
NCT01770054
First received: January 15, 2013
Last updated: March 7, 2013
Last verified: March 2013

January 15, 2013
March 7, 2013
January 2013
March 2013   (final data collection date for primary outcome measure)
Prevalence of metabolic syndrome [ Time Frame: 5 months ] [ Designated as safety issue: No ]
determination of the metabolic syndrome in subjects aged 40 years or more
Same as current
Complete list of historical versions of study NCT01770054 on ClinicalTrials.gov Archive Site
Genetic testing [ Time Frame: 5 months ] [ Designated as safety issue: No ]
Blood will be taken to evaluate the ADN pattern of this population, to compare with other Amerindian populations with a proven high prevalence of diabetes mellitus and metabolic syndrome
Same as current
determination of the prevalence of hyperinsulinemia [ Time Frame: 5 months ] [ Designated as safety issue: No ]
plasma insulin levels will be determined
Same as current
 
Prevalence of Metabolic Syndrome in Atahualpa
Evaluation of the Prevalence of Metabolic Syndrome in Atahualpa Residents Aged 40 Years or More.

A recent epidemiologic survey demonstrated a high prevalence of type 2 diabetes mellitus in Atahualpa residents. Now, the investigators attempt to evaluate the prevalence of the metabolic syndrome in adults aged 40 years or more living in this rural village of coastal Ecuador.

Several studies have shown that the occurrence of the metabolic syndrome is a risk factor for the development of cerebrovascular and ischemic heart disease. To evaluate the prevalence of the metabolic syndrome, we will invite all Atahualpa residents aged 40 years or more to participate in this study. For the purposes of this study we will obtain the waist circumference of all individuals, will measure their blood pressure using a standard protocol, and will take a blood sample to determine fasting glucose levels, HDL cholesterol levels, triglyceride levels, and plasma insulin levels.

Observational [Patient Registry]
Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
2 Months
Retention:   Samples With DNA
Description:

Blood

Non-Probability Sample

all Atahualpa residents aged 40 years or more

Metabolic Syndrome
Other: obtention of a blood sample
a blood sample will be obtained to measure glucose, HDL cholesterol, triglycerides, and for genetic testing
obtention of a blood sample
all Atahualpa residents aged 40 years or more
Intervention: Other: obtention of a blood sample
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
517
March 2013
March 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Atahualpa resident aged 40 years or more

Exclusion Criteria:

  • non-consenting persons
Both
40 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
Ecuador
 
NCT01770054
TAP 001-2013, 001-2013-01
No
Oscar H. Del Brutto, MD, Hospital Clínica Kennedy
Hospital Clínica Kennedy
Not Provided
Principal Investigator: Oscar H Del Brutto, MD Universidad de Especialidades Espiritu Santo
Hospital Clínica Kennedy
March 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP